Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 11:51 am Purchase | 2025-12-31 | 13G | PROMIS NEUROSCIENCES INC PMN | SPHERA FUNDS MANAGEMENT LTD. | 180,698 7.780% | 55,814 (+44.69%) | Filing History |
| 2026-02-05 11:48 am Purchase | 2025-12-31 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | SPHERA FUNDS MANAGEMENT LTD. | 3,153,856 4.690% | 582,430 (+22.65%) | Filing History |
| 2025-10-23 06:02 am Purchase | 2025-09-30 | 13G | PROMIS NEUROSCIENCES INC PMN | SPHERA FUNDS MANAGEMENT LTD. | 124,884 5.510% | 49,185 (+64.97%) | Filing History |
| 2025-04-10 5:28 pm Purchase | 2025-04-10 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | SPHERA FUNDS MANAGEMENT LTD. | 2,571,426 7.490% | 857,142 (+50.00%) | Filing History |
| 2025-04-10 5:27 pm Purchase | 2025-03-31 | 13G | SKYE BIOSCIENCE INC SKYE | SPHERA FUNDS MANAGEMENT LTD. | 1,476,353 4.770% | 174,835 (+13.43%) | Filing History |
| 2025-04-10 5:25 pm Sale | 2025-03-31 | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | SPHERA FUNDS MANAGEMENT LTD. | 225,107 4.780% | -78,537 (-25.86%) | Filing History |
| 2025-03-03 3:58 pm Purchase | 2025-01-17 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | SPHERA FUNDS MANAGEMENT LTD. | 1,714,284 5.210% | 1,714,284 (New Position) | Filing History |
| 2024-11-04 12:05 pm Sale | 2024-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | SPHERA FUNDS MANAGEMENT LTD. | 189,270 1.250% | -6,941,355 (-97.35%) | Filing History |
| 2024-08-20 2:36 pm Purchase | 2024-07-25 | 13G | CHEMOMAB THERAPEUTICS LTD CMMB | SPHERA FUNDS MANAGEMENT LTD. | 303,644 6.560% | 303,644 (New Position) | Filing History |
| 2024-02-08 09:51 am Purchase | 2024-01-29 | 13G | SKYE BIOSCIENCE INC SKYE | SPHERA FUNDS MANAGEMENT LTD. | 1,301,518 5.390% | 1,301,518 (New Position) | Filing History |
| 2024-02-05 09:15 am Purchase | 2023-12-31 | 13G | JASPER THERAPEUTICS INC JSPR | SPHERA FUNDS MANAGEMENT LTD. | 7,130,625 6.390% | 6,561,912 (+1153.82%) | Filing History |
| 2024-02-05 09:13 am Sale | 2023-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | SPHERA FUNDS MANAGEMENT LTD. | 328,986 3.740% | -255,303 (-43.69%) | Filing History |
| 2024-02-05 09:12 am Sale | 2023-12-31 | 13G | INOZYME PHARMA INC INZY | SPHERA FUNDS MANAGEMENT LTD. | 1,562,907 2.530% | -533,351 (-25.44%) | Filing History |
| 2024-02-05 09:10 am Purchase | 2023-12-31 | 13G | PROMIS NEUROSCIENCES INC PMN | SPHERA FUNDS MANAGEMENT LTD. | 75,699 9.990% | 1,598 (+2.16%) | Filing History |
| 2023-10-10 11:15 am Purchase | 2023-09-27 | 13G | JASPER THERAPEUTICS INC JSPR | SPHERA FUNDS MANAGEMENT LTD. | 568,713 5.130% | 568,713 (New Position) | Filing History |
| 2023-08-30 09:43 am Purchase | 2023-08-23 | 13G | PROMIS NEUROSCIENCES INC PMN | SPHERA FUNDS MANAGEMENT LTD. | 74,101 9.990% | 74,101 (New Position) | Filing History |
| 2023-06-27 10:01 am Unchanged | 2023-06-16 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | SPHERA FUNDS MANAGEMENT LTD. | 584,289 7.350% | 0 (Unchanged) | Filing History |
| 2023-06-22 11:26 am Purchase | 2023-06-16 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | SPHERA FUNDS MANAGEMENT LTD. | 584,289 7.310% | 584,289 (New Position) | Filing History |
| 2023-03-07 06:01 am Purchase | 2023-03-03 | 13G | INOZYME PHARMA INC INZY | SPHERA FUNDS MANAGEMENT LTD. | 2,096,258 5.190% | 2,096,258 (New Position) | Filing History |
| 2023-02-06 11:27 am Sale | 2022-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | SPHERA FUNDS MANAGEMENT LTD. | 69 1.990% | -72 (-51.06%) | Filing History |